293 related articles for article (PubMed ID: 16495781)
1. Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a high-risk region of China.
Chen X; Wang H; Xie W; Liang R; Wei Z; Zhi L; Zhang X; Hao B; Zhong S; Zhou G; Zhang L; Gao X; Zhu Y; He F
Pharmacogenet Genomics; 2006 Mar; 16(3):219-27. PubMed ID: 16495781
[TBL] [Abstract][Full Text] [Related]
2. Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population.
Imaizumi T; Higaki Y; Hara M; Sakamoto T; Horita M; Mizuta T; Eguchi Y; Yasutake T; Ozaki I; Yamamoto K; Onohara S; Kawazoe S; Shigematsu H; Koizumi S; Kudo S; Tanaka K
Carcinogenesis; 2009 Oct; 30(10):1729-34. PubMed ID: 19643819
[TBL] [Abstract][Full Text] [Related]
3. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age.
Tseng CS; Tang KS; Lo HW; Ker CG; Teng HC; Huang CS
Am J Gastroenterol; 2005 Aug; 100(8):1758-63. PubMed ID: 16086712
[TBL] [Abstract][Full Text] [Related]
4. CYP1A2 genetic polymorphisms and adenocarcinoma lung cancer risk in the Tunisian population.
B'chir F; Pavanello S; Knani J; Boughattas S; Arnaud MJ; Saguem S
Life Sci; 2009 May; 84(21-22):779-84. PubMed ID: 19332078
[TBL] [Abstract][Full Text] [Related]
5. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma.
Chen CC; Yang SY; Liu CJ; Lin CL; Liaw YF; Lin SM; Lee SD; Chen PJ; Chen CJ; Yu MW
Int J Epidemiol; 2005 Dec; 34(6):1310-8. PubMed ID: 16172101
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers.
Zhai Y; Zhou G; Deng G; Xie W; Dong X; Zhang X; Yu L; Yang H; Yuan X; Zhang H; Zhi L; Yao Z; Shen Y; Qiang B; He F
Gastroenterology; 2006 Jun; 130(7):2001-9. PubMed ID: 16762623
[TBL] [Abstract][Full Text] [Related]
7. Single nucleotide polymorphism in DNMT3B promoter and its association with hepatocellular carcinoma in a Moroccan population.
Ezzikouri S; El Feydi AE; Benazzouz M; Afifi R; El Kihal L; Hassar M; Akil A; Pineau P; Benjelloun S
Infect Genet Evol; 2009 Sep; 9(5):877-81. PubMed ID: 19465161
[TBL] [Abstract][Full Text] [Related]
8. The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population.
Chen X; Wang L; Zhi L; Zhou G; Wang H; Zhang X; Hao B; Zhu Y; Cheng Z; He F
Clin Pharmacol Ther; 2005 Sep; 78(3):249-59. PubMed ID: 16153396
[TBL] [Abstract][Full Text] [Related]
9. Association of genetic polymorphisms in STAT1 gene with increased risk of hepatocellular carcinoma.
Zhu ZZ; Di JZ; Gu WY; Cong WM; Gawron A; Wang Y; Zheng Q; Wang AZ; Zhu G; Zhang P; Hou L
Oncology; 2010; 78(5-6):382-8. PubMed ID: 20798561
[TBL] [Abstract][Full Text] [Related]
10. Liver intestine-cadherin (CDH17) haplotype is associated with increased risk of hepatocellular carcinoma.
Wang XQ; Luk JM; Garcia-Barcelo M; Miao X; Leung PP; Ho DW; Cheung ST; Lam BY; Cheung CK; Wong AS; Lau SS; So MT; Yu WC; Cai Q; Liu KS; Hui CK; Lau GK; Poon RT; Wong J; Fan ST
Clin Cancer Res; 2006 Sep; 12(17):5248-52. PubMed ID: 16951245
[TBL] [Abstract][Full Text] [Related]
11. Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.
Long JR; Egan KM; Dunning L; Shu XO; Cai Q; Cai H; Dai Q; Holtzman J; Gao YT; Zheng W
Pharmacogenet Genomics; 2006 Apr; 16(4):237-43. PubMed ID: 16538170
[TBL] [Abstract][Full Text] [Related]
12. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers.
Yu MW; Yang SY; Chiu YH; Chiang YC; Liaw YF; Chen CJ
Hepatology; 1999 Mar; 29(3):697-702. PubMed ID: 10051470
[TBL] [Abstract][Full Text] [Related]
13. [A study on the association of MTHFR C677T polymorphism with genetic susceptibility to hepatocellular carcinoma].
Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ
Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):196-8. PubMed ID: 16556414
[TBL] [Abstract][Full Text] [Related]
14. Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma.
Weng CJ; Hsieh YH; Tsai CM; Chu YH; Ueng KC; Liu YF; Yeh YH; Su SC; Chen YC; Chen MK; Yang SF
Ann Surg Oncol; 2010 Jul; 17(7):1808-15. PubMed ID: 20119675
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-alpha promoter gene.
Ho SY; Wang YJ; Chen HL; Chen CH; Chang CJ; Wang PJ; Chen HH; Guo HR
Cancer Causes Control; 2004 Sep; 15(7):657-63. PubMed ID: 15280623
[TBL] [Abstract][Full Text] [Related]
16. [A study about the association of detoxication gene GSTM1 polymorphism and the susceptibility to aflatoxin B1-related hepatocellular carcinoma].
Long XD; Ma Y; Wei YP; Deng ZL
Zhonghua Gan Zang Bing Za Zhi; 2005 Sep; 13(9):668-70. PubMed ID: 16174455
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity.
Kirk GD; Turner PC; Gong Y; Lesi OA; Mendy M; Goedert JJ; Hall AJ; Whittle H; Hainaut P; Montesano R; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):373-9. PubMed ID: 15734960
[TBL] [Abstract][Full Text] [Related]
18. Interaction between interleukin-1beta -31T/C gene polymorphism and drinking and smoking habits on the risk of hepatocellular carcinoma among Japanese.
Sakamoto T; Higaki Y; Hara M; Ichiba M; Horita M; Mizuta T; Eguchi Y; Yasutake T; Ozaki I; Yamamoto K; Onohara S; Kawazoe S; Shigematsu H; Koizumi S; Tanaka K
Cancer Lett; 2008 Nov; 271(1):98-104. PubMed ID: 18603357
[TBL] [Abstract][Full Text] [Related]
19. [p53 gene codon 72 polymorphism and genetic susceptibility to hepatocellular carcinoma in Chinese population].
Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):76-9. PubMed ID: 15774209
[TBL] [Abstract][Full Text] [Related]
20. Association of DLC1 gene polymorphism with susceptibility to hepatocellular carcinoma in Chinese hepatitis B virus carriers.
Dong X; Zhou G; Zhai Y; Zhang H; Yang H; Zhi L; Zhang X; Chu J; He F
Cancer Epidemiol; 2009 Oct; 33(3-4):265-70. PubMed ID: 19766077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]